Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
Atopic Dermatitis Pathophysiology: Breaking Down the Barrier

Atopic Dermatitis Pathophysiology: Breaking Down the Barrier

EOE Pediatric - Unmasking the Hidden Symptoms

EOE Pediatric - Unmasking the Hidden Symptoms

Importance of assessing key disease domains in EOE

Importance of assessing key disease domains in EOE

Daily Burden of CRSwNP

Daily Burden of CRSwNP

Uncover ASMD and GAUCHER

Uncover ASMD and GAUCHER

Approach for Patients with PAD and T2D: Focus on LDL-C Control

Approach for Patients with PAD and T2D: Focus on LDL-C Control

Approach for Patients with CAD: Focus on LDL-C Control

Approach for Patients with CAD: Focus on LDL-C Control

Cardiovascular diseases (CVDs) are the leading cause of death globally<sup>1</sup>

Cardiovascular diseases (CVDs) are the leading cause of death globally1

According to the World Health Organization, an estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths1. Of these deaths, 85% were due to myocardial infarction or stroke1.

A CV event is a highly traumatic experience for patients and their families2. It takes a heavy emotional toll, brings widespread disability and significantly impedes quality of life3,4.

Flu and Vaccination

Flu and Vaccination

Flu and Diabetes

Flu and Diabetes

Flu and Respiratory Disease

Flu and Respiratory Disease

Flu and Cardiovascular Disease

Flu and Cardiovascular Disease